A rare case of Cushing syndrome by cyclic ectopic-ACTH;Um caso raro de síndrome de Cushing associada a ACTH-ectópico cíclico

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 56, Issue 5, 2012, Pages 324-330

  Farage, Mariana ^a   Costa, Mario Alberto da Dantas Loures ^b   Godoy Matos, Amélio Fernando ^a  

^a Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

^b Oncoclinicas Institute for Research and Education   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN;

ARTICLE; CAROTID BODY TUMOR; CASE REPORT; CHEMODECTOMA; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; ECTOPIC CORTICOTROPIN PRODUCTION; FATALITY; HUMAN; MALE; MIDDLE AGED; SECRETION (PROCESS);

ACTH SYNDROME, ECTOPIC; ADRENOCORTICOTROPIC HORMONE; CAROTID BODY TUMOR; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA, EXTRA-ADRENAL;

EID: 84865383766     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302012000500008     Document Type: Article

References (39)

1. Isidori AM, Lenzi A. Ectopic ACTH syndrome. Arq Bras Endocrinol Metabol. 2007;51(8):1217-25.
2. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev. 1998;19(5):647-72.
3. Isidori AM, Kaltsas GA, Grossman AB. Ectopic ACTH syndrome. Front Horm Res. 2006;35:143-56.
4. Vilar L, Freitas Mda C, Faria M, Montenegro R, Casulari LA, Naves L, et al. Pitfalls in the diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol. 2007;51(8):1207-16.
5. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet. 2006;367(9522):1605-17.
6. Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab. 2004;89(5):2214-21.
7. Meinardi JR, Wolffenbuttel BH, Dullaart RP. Cyclic Cushing's syndrome: a clinical challenge. Eur J Endocrinol. 2007;157;245-54.
8. Orth DN. Cushing's syndrome. N Engl J Med. 1995;332:791-803.
9. Grufferman S, Gillman MW, Pasternak LR, Peterson CL, Young Jr WG. Familial carotid body tumors: case report and epidemiologic review. Cancer. 1980;46:2116-22.
10. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg. 1990;102:382-90.
11. Drovdlic CM, Myers EN, Peters JA, Baysal BE, Brackmann DE, Slattery WH 3rd, et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope. 2001;111:1822-7.
12. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90: 2110-6.
13. Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755-64; discussion 764-756 (1999).
14. Maher ER, Eng C. The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet. 2002;11:2347-54.
15. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000;26:268-70.
16. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. AM J Hum Genet. 2001;69:49-54.
17. Becker M, Aron DC. Ectopic ACTH syndrome and CRH-mediated Cushing's syndrome. Endocrinol Metab Clin North Am. 1994;23:585-606.
18. Martin E, Rutishauser E, Bach J. [Cushing syndrome in a patient having had a tumor of the carotid paraganglion.]. Ann Endocrinol (Paris). 1952;13:938-42.
19. Boscaro M, Merola G, Sonino N, Menegus AM, Sartori F, Mantero F. Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing's syndrome: in vivo and in vitro studies. J Endocrinol Invest. 1985;8:417-21.
20. Seregni E, Chiti A, Bombardieri E. Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results. Eur J Nucl Med. 1998;25:639-58.
21. Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg. 2001;25:934-40.
22. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2006;91:371-7.
23. Mansi L, Rambaldi PF, Panza N, Esposito D, Esposito V, Pastore V. Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. Eur J Endocrinol. 1997;137:688-90.
24. von Werder K, Muller OA, Stalla GK. Somatostatin analogs in ectopic corticotropin production. Metabolism. 1996;45:129-31.
25. Pivonello R, Ferone D, Lamberts SW, Colao A. Cabergoline plus lanreotide for ectopic Cushing's syndrome. N Engl J Med. 2005;352;2457-8.
26. Winquist EW, Laskey J, Crump M, Khamsi F, Shepherd FA. Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production. J Clin Oncol. 1995;13:157-64.
27. Beardwell CG, Adamson AR, Shalet SM. Prolonged remission in florid Cushing's syndrome following metyrapone treatment. Clin Endocrinol (Oxf). 1981;14:485-92.
28. Boscaro M, Sonino N, Rampazzo A, Mantero F. Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing's disease before and after ketoconazole treatment. Clin Endocrinol (Oxf). 1987;27:461-7.
29. Burrin JM, Yeo TH, Ashby MJ, Bloom SR. Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo. J Endocrinol. 1986;108:37-41.
30. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med. 1987;317:812-8.
31. Sonino N, Boscaro M. Medical therapy for Cushing's disease. Endocrinol Metab Clin North Am. 1999;28:211-22.
32. Biller BMK, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93:2454-62.
33. Luton JP, Mahoudeau JA, Bouchard P,Thieblot P, Hautecouverture M, Simon D, et al. Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases. N Engl J Med. 1979;300:459-64.
34. Johnson TN, Canada TW. Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor. Ann Pharmacother. 2007;41:350-3.
35. de Bruin C, Feelders RA, Lamberts SW, Hofland LJ. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. Rev Endocr Metab Disord. 2009;10:91-102.
36. Bertagna X, Favrod-Coune C, Escourolle H, Beuzeboc P, Christoforov B, Girard F, et al. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. J Clin Endocrinol Metab. 1989;68:988-91.
37. Vignati F, Loli P. Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism. J Clin Endocrinol Metab. 1996;81:2885-90.
38. de Herder WW, Krenning EP, Malchoff CD, Hofland LJ, Reubi JC, Kwekkeboom DJ, et al. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med. 1994;96:305-12.
39. Hofland LJ, Lamberts SW. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev. 2003;24:28-47.